ProQR Therapeutics N.V. (PRQR) News
NASDAQ: PRQRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.04-0.01 (-0.95%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PRQR news summary
We found 5 recent headlines mentioning ProQR Therapeutics N.V. (PRQR): 0 in the past week and 5 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, PRQR is down 0.95% at $1.04. The most recent story, "ProQR Therapeutics N.V. Reports Third Quarter 2026 Operating and Financial Results", was published by Nasdaq on Nov 13, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest ProQR Therapeutics N.V. headlines
- ProQR Therapeutics N.V. Reports Third Quarter 2026 Operating and Financial ResultsProQR Therapeutics N.V. reported its operating and financial results for the third quarter ended September 30, 2026, and provided a clinical pipeline update. The company announced that Cohorts 1 and…Nasdaq
- ProQR Therapeutics N.V. Announces Third Quarter 2026 Operating and Financial ResultsProQR Therapeutics N.V. reported its financial and operating results for the third quarter ended September 30, 2026, and provided a business update. At September 30, 2026, ProQR held cash and cash…Nasdaq
- ProQR Therapeutics Q3 Sales Increase(RTTNews) - ProQR Therapeutics (PRQR) released Loss for third quarter of -EUR12.447 millionNasdaq
- ProQR Therapeutics N.V. to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming ConferencesProQR Therapeutics N.V. announced upcoming presentations highlighting clinical and preclinical progress with AX-0810 and AX-0811 and the broader Axiomer RNA editing platform at TIDES Europe, The…Nasdaq
- ProQR to Present Clinical and Preclinical Progress from AX-0810 and AX-0811 at Upcoming ConferencesLEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative…GlobeNewswire